Article (Scientific journals)
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
ANDROSOVA, Ganna; KRAUSE, Roland; Borghei, Mojgansadat et al.
2017In Epilepsia, p. 1-8
Peer Reviewed verified by ORBi
 

Files


Full Text
Androsova_et_al-2017-Epilepsia.pdf
Publisher postprint (424.06 kB)
Request a copy
Annexes
epi13871-sup-0001-SupInfo.docx
(129.24 kB)
Supplementary Materials
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
retention; efficacy; adverse drug reactions; drug response; seizure freedom
Abstract :
[en] Objective: Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a common epilepsy syndrome that is often poorly controlled by antiepileptic drug (AED) treatment. Comparative AED effectiveness studies in this condition are lacking. Wereport retention, efficacy, and tolerability in a cohort of patients with MTLE-HS. Methods: Clinical data were collected from a European database of patients with epilepsy. We estimated retention, 12-month seizure freedom, and adverse drug reaction (ADR) rates for the 10 most commonly used AEDs in patients with MTLE-HS. Results: Seven hundred sixty-seven patients with a total of 3,249 AED trials were included. The highest 12-month retention rates were observed with carbamazepine (85.9%), valproate (85%), and clobazam (79%). Twelve-month seizure freedom rates varied from 1.2% for gabapentin and vigabatrin to 11% for carbamazepine. Response rates were highest for AEDs that were prescribed as initial treatment and lowest for AEDs that were used in a third or higher instance. ADRs were reported in 47.6% of patients, with the highest rates observed with oxcarbazepine (35.7%), topiramate (30.9%), and pregabalin (27.4%), and the lowest rates with clobazam (6.5%), gabapentin (8.9%), and lamotrigine (16.6%). The most commonly reported ADRs were lethargy and drowsiness, dizziness, vertigo and ataxia, and blurred vision and diplopia. Significance: Our results did not demonstrate any clear advantage of newer versus older AEDs. Our results provide useful insights into AED retention, efficacy, and ADR rates in patients with MTLE-HS.
Disciplines :
Human health sciences: Multidisciplinary, general & others
Author, co-author :
ANDROSOVA, Ganna  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
KRAUSE, Roland   ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Borghei, Mojgansadat;  Université Libre de Bruxelles, Brussels, Belgium > Laboratory of Experimental Neurology
Wassenaar, Merel;  Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands
Auce, Pauls;  Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom > Department of Molecular and Clinical Pharmacology ; The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
Avbersek, Andreja;  UCL Institute of Neurology, London, United Kingdom > Department of Clinical and Experimental Epilepsy
Becker, Felicitas;  Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
Berghuis, Bianca;  Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands
Campbell, Ellen;  Belfast Health and Social Care Trust, Belfast, United Kingdom
Coppola, Antonietta;  University of Genoa, Genoa, Italy > Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health
Francis, Ben;  University of Liverpool, Liverpool, United Kingdom > Department of Biostatistics
Wolking, Stefan;  Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
Cavalleri, Gianpiero L.;  Royal College of Surgeons in Ireland, Dublin, Ireland > Molecular and Cellular Therapeutics
Craig, John;  Belfast Health and Social Care Trust, Belfast, United Kingdom
Delanty, Norman;  Royal College of Surgeons in Ireland, Dublin, Ireland > Molecular and Cellular Therapeutics ; Beaumont Hospital, Dublin, Ireland > Department of Neurology
Koeleman, Bobby P. C.;  University Medical Center Utrecht, Utrecht, Netherlands > Department of Genetics
Kunz, Wolfram S.;  University of Bonn, Bonn, Germany > Department of Epileptology
Lerche, Holger;  Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
Marson, Anthony G.;  Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom > Department of Molecular and Clinical Pharmacology ; The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
Sander, Josemir W.;  Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands ; NIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, United Kingdom ; The Chalfont Centre for Epilepsy, Chalfont St. Peters, United Kingdom
Sills, Graeme J.;  Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom > Department of Molecular and Clinical Pharmacology
Striano, Pasquale;  University of Genoa, Genoa, Italy > Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health
Zara, Federico;  Laboratory of Neurogenetics and Neuroscience, Institute G. Gaslini, Genoa, Italy
Sisodiya, Sanjay M.;  UCL Institute of Neurology, London, United Kingdom > Department of Clinical and Experimental Epilepsy ; The Chalfont Centre for Epilepsy, Chalfont St. Peters, United Kingdom
Depondt, Chantal;  Université Libre de Bruxelles, Brussels, Belgium > Laboratory of Experimental Neurology ; Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium > Department of Neurology
the EpiPGX Consortium
More authors (16 more) Less
 These authors have contributed equally to this work.
External co-authors :
yes
Language :
English
Title :
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
Publication date :
31 August 2017
Journal title :
Epilepsia
ISSN :
0013-9580
eISSN :
1528-1167
Publisher :
Blackwell Science, Malden, United States - Massachusetts
Pages :
1-8
Peer reviewed :
Peer Reviewed verified by ORBi
Focus Area :
Systems Biomedicine
European Projects :
FP7 - 602461 - BIOCOG - Biomarker Development for Postoperative Cognitive Impairment in the Elderly
Funders :
European Commission. Grant Number: 279062
Framework of the EU-funded FP7 research program BioCog
Department of Health's NIHR Biomedical Research Centre's funding scheme
Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie
University of Liverpool
Italian League Against Epilepsy (LICE)
German Society for Epileptology
Foundation no epilep
Dr. Marvin Weil Epilepsy Research Fund
Ministero della Salute
European Community Sixth
Telethon Foundation
Italian League Against Epilepsy
CE - Commission Européenne
European Union
Available on ORBilu :
since 16 October 2017

Statistics


Number of views
135 (12 by Unilu)
Number of downloads
12 (1 by Unilu)

Scopus citations®
 
27
Scopus citations®
without self-citations
22
OpenCitations
 
23
OpenAlex citations
 
32
WoS citations
 
23

Bibliography


Similar publications



Contact ORBilu